Inflection Biosciences
PrivateLast Round
Seed
Mar 9, 2015
Total Funding Raised
$1.38M
Company Overview
Inflection Biosciences is a biotechnology company that develops small molecule therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inflection Biosciences Comparables
Compare Inflection Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synnovation Therapeutics | 80% | |
| AUM Biosciences | 78% | |
| Ability Pharmaceuticals | 77% |
Inflection Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 9, 2015 | ||||
| Seed | Jun 4, 2013 |
Inflection Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Enterprise Ireland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2015
$790K raised in Seed round.
- Jun 4, 2013
$590K round with Enterprise Ireland as an investor.
Inflection Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inflection Biosciences's valuation, stock price, and market status.
Is Inflection Biosciences a public or private company?
Inflection Biosciences is a private company.
What is the current stock price of Inflection Biosciences?
Inflection Biosciences is a private company with no public stock price. Caplight tracks Inflection Biosciences's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Inflection Biosciences worth (valuation)?
Valuation information for Inflection Biosciences is not publicly available.
Can I buy Inflection Biosciences stock?
Inflection Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inflection Biosciences's last funding round?
Inflection Biosciences's most recent funding round was Seed on March 9, 2015.
Who are the main investors in Inflection Biosciences?
Key investors in Inflection Biosciences include European Commission, Enterprise Ireland.
Will Inflection Biosciences IPO soon?
No public IPO plans have been announced for Inflection Biosciences.
How can I track Inflection Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inflection Biosciences's secondary market activity and sign up for updates.